Bleeding Complications of Percutaneous Kidney Biopsy: Does Gender Matter?

Aksharaa Anpalahan; Eva Malacova; Katharine Hegerty; Andrew Malett; Dwarakanathan Ranganathan; Helen G Healy; Pedro Henrique Franca Gois

doi:10.34067/KID.0002432021

Bleeding Complications of Percutaneous Kidney Biopsy: Does Gender Matter?

Kidney360. 2021 Jun 16;2(8):1308-1312. doi: 10.34067/KID.0002432021. eCollection 2021 Aug 26.

Authors

Aksharaa Anpalahan¹, Eva Malacova², Katharine Hegerty³, Andrew Malett^{4

5}, Dwarakanathan Ranganathan¹, Helen G Healy^{1

5

6}, Pedro Henrique Franca Gois^{1

5

6}

Affiliations

¹ Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
² Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
³ Metro South and Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
⁴ Department of Renal Medicine, Townsville University Hospital, Townsville, Queensland, Australia.
⁵ Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
⁶ Conjoint Kidney Research Laboratory, Chemical Pathology-Pathology Queensland, Brisbane, Queensland, Australia.

Abstract

The incidence of bleeding complications after percutaneous kidney biopsies is low.Female sex may be associated with a greater risk for bleeding complications after percutaneous kidney biopsies.This association and the plausible mechanisms require further evaluation in prospective study.

Keywords: biopsy; bleeding complications; clinical nephrology; nephrectomy; percutaneous kidney biopsy; predictors.

MeSH terms

Biopsy / adverse effects
Female
Hemorrhage* / diagnosis
Humans
Kidney* / pathology
Prospective Studies
Retrospective Studies